Cited 48 times in
Health-Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer After Endocrine Therapy
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.